Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke

Table 3 Binary and multiple linear regression for predicting mortality and three-month mRS based on AST/ALT ratio

	Three–month mortality^*				Three-month mRS
Variable	Odds ratio	SE	95% C. I for OR	P-value	Standardized Coefficients B	95.0% C.I. for B	P-value	Adjusted R square
Age	1.06	0.01	1.04-1.09	< 0.001	0.334	0.03-0.07	< 0.001
Gender	1.03	0.30	0.56-1.88	0.914	0.033	−0.34-0.62	0.571
Underlying disease	1.49	0.29	0.83-2.68	0.176	0.016	−0.40-0.54	0.769
History of smoking	6.67	0.35	3.32-13.37	< 0.001	0.265	0.71-1.75	< 0.001
AST/ALT	2.49	0.30	1.37-4.52	0.003	0.153	0.17-1.06	0.007
Model Summary								0.21

AST aspartate transaminase, ALT alanine transaminase, mRS modified Rankin Scale, C.I. confidence interval, SE standard error, OR odds ratio
^*Residuals were tested for normality using Q-Q-plot (Fig. 2). P-value< 0.05 is statistically significant

ISSN: 1471-2377